Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports
NCT ID: NCT01812499
Last Updated: 2013-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
131 participants
OBSERVATIONAL
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In 2010 the University Hospitals Leuven introduced a new electronic patient incident report system for transfusion events.
In this study the investigators will analyze the reported blood transfusion events to detect the most common causes of blood transfusion events and the weakest link in the blood transfusion chain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transfusion Medicine - Prevention of Bedside Errors
NCT00127556
The Effect of Red Blood Cells Transfusion in Trauma Patients
NCT01746953
Transfusion Surveillance in Anaesthesia
NCT06403163
Evaluation of the Quality of the Transfusion Practice at Rigshospitalet, Copenhagen University Hospital
NCT00192920
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
NCT03354559
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data will be drawn from the incident report system. Data concerning the number of transfused blood products will be required from the Medical Administration Service.
Events will be classified according to the severity and the cause of the event. The different settings where the events took place will be compared using a chi-square test (p\<0,05).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both severe accidents and near misses were included
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Devos, MD, PhD
Role: STUDY_DIRECTOR
Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Els Costermans, RN
Role: PRINCIPAL_INVESTIGATOR
Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S55141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.